Close

More on JNJ

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-1.9% Growth)
- Ratings (4.8 Score)
- Holders
- Dividends (3% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (4/16/24)
- M&A (12/31/20 *Est)
- M&A (3/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

JNJ Cash Flow Statement

Click line-items for a historical chart and %
CASH FLOW FROM OPERATING ACTIVITIES
Net earnings
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property and intangibles 2.7B
Stock based compensation 704M
Deferred tax provision 215M
Accounts receivable allowances -10M
Changes in assets and liabilities, net of effects from acquisitions:
Increase in accounts receivable -736M
Increase in inventories -408M
Decrease in accounts payable and accrued liabilities -1.22B
Increase in other current and non-current assets -379M
Increase in other current and non-current liabilities -1.39B
NET CASH FLOWS FROM OPERATING ACTIVITIES 12.11B
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment -2.13B
Proceeds from the disposal of assets 873M
Acquisitions, net of cash acquired -4.05B
Purchases of investments -27.68B
Sales of investments 30.44B
Other -37M
NET CASH USED BY INVESTING ACTIVITIES -2.59B
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends to shareholders -6.45B
Repurchase of common stock -6.95B
Proceeds from short-term debt 149M
Retirement of short-term debt -3.93B
Proceeds from long-term debt 11.95B
Retirement of long-term debt -953M
Proceeds from the exercise of stock options/ excess tax benefits
NET CASH USED BY FINANCING ACTIVITIES -5.09B
Effect of exchange rate changes on cash and cash equivalents 33M
Decrease in cash and cash equivalents 4.47B
Cash and Cash equivalents, beginning of period 13.73B
CASH AND CASH EQUIVALENTS, END OF PERIOD 18.21B
Acquisitions
Fair value of assets acquired 4.09B
Fair value of liabilities assumed and non-controlling interests -44M
Net cash paid for acquisitions 4.05B